CSIMarket
 


Bluebird Bio Inc   (BLUE)
Other Ticker:  
 

Bluebird Bio Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Bluebird Bio Inc in the third quarter 2023?
Bluebird Bio Inc recorded a cumulative net loss of $-91 million during 12 months ending in the third quarter 2023, resulting in a negative return on equity (ROE) of -34.32%.

Within the Biotechnology & Pharmaceuticals industry 38 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 2968, from total ROE ranking in the second quarter 2023 at 3102.

What is ROE?



Return On Equity (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change 40.09 % 60.46 % 34.75 % -47.54 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -91 -96 -123 -267 -476
Return On Equity (TTM) -34.32 % -38.42 % -55.36 % -133.53 % -194.95 %
BLUE's Total Ranking # 2968 # 3102 # 3418 # 4412 # 4099
Equity (TTM) in Millions 223 289 355 196 159
Seq. Equity Change -23 % -18.53 % 80.67 % 23.6 % -11.8 %
Seq. Net Income Change - - -34.1 % - -

Return On Equity Company Ranking
Within: No.
Industry # 39
Sector # 355
Overall # 2968

Return On Equity Statistics
High Average Low
-20.05 %
-50.92 %
-194.95 %
(Sep. 30, 2015)   (Sep 30 2022)





BLUE Annual Return On Equity (Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Total Equity in Millions 196 374 1,355 1,285 1,885
Y / Y Equity Change -47.54 % -72.38 % 5.45 % -31.83 % 16.12 %
Net Income in Millions -267 -819 -619 -790 -556
Y / Y Net Income Change - - - - -
Return On Equity -135.77 % -218.92 % -45.66 % -61.45 % -29.48 %





More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BLUE's' Return on Equity at Yahoo Finance
BLUE's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for BLUE's Competitors
Return On Equity for Bluebird Bio Inc 's Suppliers
Roe for BLUE's Customers




Companies with similar Return On Equity at Sep 30 2023, within Healthcare Sector ROE


Date modified: 2023-11-08T17:16:43+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com